Tapewire

Nasdaq · USD

RCKT

ROCKET PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
5627
SEC CIK
0001281895
Parsed reports
343

Last 12 months

Inside the activity.

1 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202610
Feb 202606
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202606
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 18, 2024 Filed Jan 22, 2024 21:05 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 1,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-003111 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
December 07, 2023 Filed Dec 13, 2023 01:51 UTC
Woods KeithDirector
GrantStock Option (Right to Buy) · Derivative 11,960 $0.00 Strike: $26.30 $0.00
Disclosure

SEC source: 0001140361-23-057390 · form4.xml · derivative · entry 2

Woods Keith · CIK 0001996804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,960

Underlying: Common Stock · 11,960 shares

Expires 2033-12-07

F2 · derivative.exercise_date: This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024.

Read SEC document
December 07, 2023 Filed Dec 13, 2023 01:51 UTC
Woods KeithDirector
GrantStock Option (Right to Buy) · Derivative 20,522 $0.00 Strike: $26.30 $0.00
Disclosure

SEC source: 0001140361-23-057390 · form4.xml · derivative · entry 1

Woods Keith · CIK 0001996804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,522

Underlying: Common Stock · 20,522 shares

Expires 2033-12-07

F1 · derivative.exercise_date: This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026.

Read SEC document
November 15, 2023 Filed Nov 16, 2023 19:24 UTC SaleCommon Stock 20,000 $22.53 $450,646.00
Disclosure

SEC source: 0001140361-23-053713 · form4.xml · nonDerivative · entry 1

Makker Gotham · CIK 0001726391 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Simran Investment Group

Disclosed balance after: 1,296,497

F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement").

F2 · kind: The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement.

F3 · ownership.nature: The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 23:58 UTC
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053705 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,628

Underlying: Common Stock · 725 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 23:58 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053705 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
November 14, 2023 Filed Nov 17, 2023 00:17 UTC
Patel KinnariSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053711 · form4.xml · derivative · entry 4

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,950

Underlying: Common Stock · 3,989 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years.

F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years.

Read SEC document
November 14, 2023 Filed Nov 17, 2023 00:17 UTC
Patel KinnariSee Remarks
Exercise / conversionCommon Stock 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053711 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
November 14, 2023 Filed Nov 17, 2023 00:09 UTC
Shah GauravDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053709 · form4.xml · derivative · entry 4

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,898

Underlying: Common Stock · 7,979 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
November 14, 2023 Filed Nov 17, 2023 00:09 UTC
Shah GauravDirector · CEO
Exercise / conversionCommon Stock 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-053709 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 532,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
October 20, 2023 Filed Oct 25, 2023 13:38 UTC
Militello JohnSee Remarks
SaleCommon Stock 564 $17.06 $9,622.97
Disclosure

SEC source: 0001140361-23-049426 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,760

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F2 · kind: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement.

Read SEC document
October 18, 2023 Filed Oct 20, 2023 22:37 UTC Amendment
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 1,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-049079 · form4.xml · derivative · entry 3

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,518

Underlying: Common Stock · 1,586 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F6 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
October 18, 2023 Filed Oct 20, 2023 22:37 UTC Amendment
Militello JohnSee Remarks
Exercise / conversionCommon Stock 1,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-049079 · form4.xml · nonDerivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Represents shares of Common Stock received upon vesting of an RSU award.

F4 · shares: Represents shares of Common Stock received upon vesting of an RSU award.

F2 · balance_after: The error in the original Form 4 was carried through in Column 5 of Table 1 in subsequent filings but is corrected in the total amount of securities owned in this Form 4.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 20:11 UTC
Patel KinnariSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 3,333 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-047589 · form4.xml · derivative · entry 4

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adaptive Technology LLC

Disclosed balance after: 0

Underlying: Common Stock · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on October 5, 2021, with the remaining shares vesting in equal annual installments over the following two years.

F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on October 5, 2021, with the remaining shares vesting in equal annual installments over the following two years.

F2 · ownership.nature: The shares are held indirectly through Adaptive Technology, LLC, ("Adaptive Technology") a limited liability company that is owned and managed by the reporting person's husband. The restricted stock units were granted to Adaptive Technology, in connection with a Consulting Agreement for information technology services provided to the Company.

Read SEC document
October 05, 2023 Filed Oct 10, 2023 20:11 UTC
Patel KinnariSee Remarks
Exercise / conversionCommon Stock 3,333 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-047589 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adaptive Technology LLC

Disclosed balance after: 101,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F2 · ownership.nature: The shares are held indirectly through Adaptive Technology, LLC, ("Adaptive Technology") a limited liability company that is owned and managed by the reporting person's husband. The restricted stock units were granted to Adaptive Technology, in connection with a Consulting Agreement for information technology services provided to the Company.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 21:02 UTC SaleCommon Stock 4,677 $21.14 $98,863.83
Disclosure

SEC source: 0001140361-23-046452 · form4.xml · nonDerivative · entry 2

Makker Gotham · CIK 0001726391 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Simran Investment Group

Disclosed balance after: 1,316,497

F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement").

F2 · kind: The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement.

F3 · ownership.nature: The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.

Read SEC document
September 28, 2023 Filed Oct 2, 2023 21:02 UTC SaleCommon Stock 10,312 $21.03 $216,879.92
Disclosure

SEC source: 0001140361-23-046452 · form4.xml · nonDerivative · entry 1

Makker Gotham · CIK 0001726391 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Simran Investment Group

Disclosed balance after: 1,321,174

F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement").

F2 · kind: The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement.

F3 · ownership.nature: The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
PurchasePre-funded Warrant (right to buy) · Derivative 3,126,955 $15.99 Strike: $0.01 $50,000,010.45
Disclosure

SEC source: 0000902664-23-004827 · ownership.xml · derivative · entry 1

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 3,126,955

Underlying: Common Stock · 3,126,955 shares

Expires not disclosed

F1 · derivative.exercise_date: Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after September 15, 2023, exercise the Pre-funded Warrant until it has been exercised in full. The Pre-funded Warrants reported herein contain an exercise limitation prohibiting the holder from exercising the Pre-Funded Warrants until such time as the holder, together with the Reporting Persons and certain other related parties, would not beneficially own after any such exercise more than 9.99% of the then issued and outstanding Common Stock (the "Blocker"). Due to the Blocker, the Pre-funded Warrants beneficially owned by the Reporting Persons are not presently exercisable.

F1 · derivative.expiration_date: Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after September 15, 2023, exercise the Pre-funded Warrant until it has been exercised in full. The Pre-funded Warrants reported herein contain an exercise limitation prohibiting the holder from exercising the Pre-Funded Warrants until such time as the holder, together with the Reporting Persons and certain other related parties, would not beneficially own after any such exercise more than 9.99% of the then issued and outstanding Common Stock (the "Blocker"). Due to the Blocker, the Pre-funded Warrants beneficially owned by the Reporting Persons are not presently exercisable.

F2 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherEquity Swap (obligation to sell) · Derivative 1 Not disclosed Strike: $22.05 Not disclosed
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · derivative · entry 6

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 500,000 shares

Expires 2023-08-28

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F3 · kind: On August 28, 2023, the equity swap entered into by RTW Master Fund, Ltd. previously reported on the 2018 Form 4, expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Master Fund, Ltd. into an equity swap (obligation to buy); RTW Master Fund, Ltd. in fact entered into an equity swap (obligation to sell).

F3 · price: On August 28, 2023, the equity swap entered into by RTW Master Fund, Ltd. previously reported on the 2018 Form 4, expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Master Fund, Ltd. into an equity swap (obligation to buy); RTW Master Fund, Ltd. in fact entered into an equity swap (obligation to sell).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherEquity Swap (obligation to buy) · Derivative 1 Not disclosed Strike: $22.05 Not disclosed
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · derivative · entry 5

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 500,000 shares

Expires 2023-08-28

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F2 · kind: On August 28, 2023, the equity swap entered into by RTW Innovation Master Fund, Ltd. previously reported on the Form 4 filed by the Reporting Persons on August 29, 2018 (the "2018 Form 4"), expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Innovation Master Fund, Ltd. into an equity swap (obligation to sell); RTW Innovation Master Fund, Ltd. in fact entered into an equity swap (obligation to buy).

F2 · price: On August 28, 2023, the equity swap entered into by RTW Innovation Master Fund, Ltd. previously reported on the Form 4 filed by the Reporting Persons on August 29, 2018 (the "2018 Form 4"), expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Innovation Master Fund, Ltd. into an equity swap (obligation to sell); RTW Innovation Master Fund, Ltd. in fact entered into an equity swap (obligation to buy).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherCommon Stock 500,000 $15.87 $7,935,000.00
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · nonDerivative · entry 4

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 18,157,605

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F3 · kind: On August 28, 2023, the equity swap entered into by RTW Master Fund, Ltd. previously reported on the 2018 Form 4, expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Master Fund, Ltd. into an equity swap (obligation to buy); RTW Master Fund, Ltd. in fact entered into an equity swap (obligation to sell).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherCommon Stock 500,000 $22.05 $11,025,000.00
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · nonDerivative · entry 3

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 17,657,605

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F3 · kind: On August 28, 2023, the equity swap entered into by RTW Master Fund, Ltd. previously reported on the 2018 Form 4, expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Master Fund, Ltd. into an equity swap (obligation to buy); RTW Master Fund, Ltd. in fact entered into an equity swap (obligation to sell).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherCommon Stock 500,000 $15.87 $7,935,000.00
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · nonDerivative · entry 2

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 18,157,605

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F2 · kind: On August 28, 2023, the equity swap entered into by RTW Innovation Master Fund, Ltd. previously reported on the Form 4 filed by the Reporting Persons on August 29, 2018 (the "2018 Form 4"), expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Innovation Master Fund, Ltd. into an equity swap (obligation to sell); RTW Innovation Master Fund, Ltd. in fact entered into an equity swap (obligation to buy).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
RTW INVESTMENTS, LPDirector · 10% owner · See Remarks
WONG RODERICKDirector · 10% owner
OtherCommon Stock, $0.01 par value ("Common Stock") 500,000 $22.05 $11,025,000.00
Disclosure

SEC source: 0000902664-23-004651 · ownership.xml · nonDerivative · entry 1

RTW INVESTMENTS, LP · CIK 0001493215 · Director · 10% owner · See Remarks

WONG RODERICK · CIK 0001493280 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 18,657,605

F1 · security: This Form 4 is being filed in connection with the equity swap transactions described below. After the transactions reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.

F2 · kind: On August 28, 2023, the equity swap entered into by RTW Innovation Master Fund, Ltd. previously reported on the Form 4 filed by the Reporting Persons on August 29, 2018 (the "2018 Form 4"), expired and settled in accordance with its terms. The 2018 Form 4 reported the entry by RTW Innovation Master Fund, Ltd. into an equity swap (obligation to sell); RTW Innovation Master Fund, Ltd. in fact entered into an equity swap (obligation to buy).

F4 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Read SEC document
August 17, 2023 Filed Aug 21, 2023 20:05 UTC
Militello JohnSee Remarks
SaleCommon Stock 284 $15.47 $4,393.76
Disclosure

SEC source: 0001140361-23-040693 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,570

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
August 17, 2023 Filed Aug 21, 2023 20:05 UTC
Patel KinnariSee Remarks
SaleCommon Stock 1,534 $15.47 $23,732.51
Disclosure

SEC source: 0001140361-23-040695 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,448

F1 · security: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
August 17, 2023 Filed Aug 21, 2023 20:05 UTC
Shah GauravDirector · CEO
SaleCommon Stock 4,767 $15.47 $73,750.26
Disclosure

SEC source: 0001140361-23-040694 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 524,854

F1 · security: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:17 UTC
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039905 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,353

Underlying: Common Stock · 725 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:17 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 725 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039905 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:16 UTC
Patel KinnariSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039904 · form4.xml · derivative · entry 4

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,993

Underlying: Common Stock · 3,989 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:16 UTC
Patel KinnariSee Remarks
Exercise / conversionCommon Stock 3,989 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039904 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:06 UTC
Shah GauravDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039901 · form4.xml · derivative · entry 4

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,877

Underlying: Common Stock · 7,979 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:06 UTC
Shah GauravDirector · CEO
Exercise / conversionCommon Stock 7,979 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-039901 · form4.xml · nonDerivative · entry 1

Shah Gaurav · CIK 0001725922 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 529,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
July 20, 2023 Filed Jul 24, 2023 20:05 UTC
Militello JohnSee Remarks
SaleCommon Stock 573 $19.03 $10,905.91
Disclosure

SEC source: 0001140361-23-035859 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,129

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:05 UTC
Militello JohnSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 1,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-035428 · form4.xml · derivative · entry 2

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,104

Underlying: Common Stock · 1,586 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:05 UTC
Militello JohnSee Remarks
Exercise / conversionCommon Stock 1,586 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-035428 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,702

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 3,590 $13.93 Strike: $21.56 $50,008.70
Disclosure

SEC source: 0001140361-23-031526 · form4.xml · derivative · entry 2

Bjork Elisabeth · CIK 0001810406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,590

Underlying: Common Stock · 3,590 shares

Expires 2033-06-22

F2 · derivative.exercise_date: This option represents a right to purchase a total of 3,590 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031526 · form4.xml · derivative · entry 1

Bjork Elisabeth · CIK 0001810406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 19:47 UTC GrantStock Option (Right to Buy) · Derivative 2,872 $13.93 Strike: $21.56 $40,006.96
Disclosure

SEC source: 0001140361-23-031529 · form4.xml · derivative · entry 2

Makker Gotham · CIK 0001726391 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,872

Underlying: Common Stock · 2,872 shares

Expires 2033-06-22

F2 · derivative.exercise_date: This option represents a right to purchase a total of 2,872 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 19:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031529 · form4.xml · derivative · entry 1

Makker Gotham · CIK 0001726391 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:48 UTC
WONG RODERICKDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 3,590 $13.93 Strike: $21.56 $50,008.70
Disclosure

SEC source: 0001140361-23-031531 · form4.xml · derivative · entry 2

WONG RODERICK · CIK 0001493280 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,590

Underlying: Common Stock · 3,590 shares

Expires 2033-06-22

F2 · derivative.exercise_date: This option represents a right to purchase a total of 3,590 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:48 UTC
WONG RODERICKDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031531 · form4.xml · derivative · entry 1

WONG RODERICK · CIK 0001493280 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:48 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031532 · form4.xml · derivative · entry 1

Yalamanchi Naveen · CIK 0001725743 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031530 · form4.xml · derivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031528 · form4.xml · derivative · entry 1

BOESS CARSTEN · CIK 0001277495 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 5,026 $13.93 Strike: $21.56 $70,012.18
Disclosure

SEC source: 0001140361-23-031527 · form4.xml · derivative · entry 2

GRANADILLO PEDRO P · CIK 0001217544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,026

Underlying: Common Stock · 5,026 shares

Expires 2033-06-22

F2 · derivative.exercise_date: This option represents a right to purchase a total of 5,026 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031527 · form4.xml · derivative · entry 1

GRANADILLO PEDRO P · CIK 0001217544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 23:47 UTC GrantStock Option (Right to Buy) · Derivative 25,850 $0.00 Strike: $21.56 $0.00
Disclosure

SEC source: 0001140361-23-031525 · form4.xml · derivative · entry 1

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,850

Underlying: Common Stock · 25,850 shares

Expires 2033-06-22

F1 · derivative.exercise_date: This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:05 UTC
Militello JohnSee Remarks
SaleCommon Stock 245 $21.38 $5,236.88
Disclosure

SEC source: 0001140361-23-025741 · form4.xml · nonDerivative · entry 1

Militello John · CIK 0001662170 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,116

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:05 UTC
Patel KinnariSee Remarks
SaleCommon Stock 1,330 $21.38 $28,428.75
Disclosure

SEC source: 0001140361-23-025743 · form4.xml · nonDerivative · entry 1

Patel Kinnari · CIK 0001725929 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,993

F1 · security: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.